Advertisement

Critical Care

, 20:366 | Cite as

Hybrid blood purification strategy in pediatric septic shock

  • Gabriella Bottari
  • Fabio Silvio Taccone
  • Andrea Moscatelli
Open Access
Letter

Keywords

Septic Shock Mean Arterial Pressure Pediatric Intensive Care Unit Continuous Renal Replacement Therapy Procalcitonin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

CC

Cartridge column

CRRT

Continuous renal replacement therapy

EBT

Extracorporeal blood purification technique

HCO

High cutoff

MAP

Mean arterial pressure

Extracorporeal blood purification techniques (EBTs) are emerging as beneficial interventions in the management of sepsis. Although the combination of different EBTs has also been suggested as a potentially effective approach in the early phases of sepsis [1, 2], no data are available for pediatric septic shock.

We reported a case of refractory septic shock in a 12-year-old girl, with a clinical history of acute lymphatic leukemia and recent chemotherapy, who was admitted to the emergency department (ED) because of fever and fatigue. In the ED ward, mean arterial pressure (MAP) was below 50 mmHg and did not improve after initial fluid resuscitation (20 ml/kg). Empiric antimicrobial therapy was initiated and the patient was admitted to the pediatric intensive care unit. Because of severe persistent hypotension with arterial lactate concentrations of 74 mg/dl, epinephrine and norepinephrine were initiated at 0.2 μg/kg/min and 0.08 μg/kg/min, respectively. Six hours after admission, the patient remained severely hypotensive (MAP of 45 mmHg) despite fluid and vasopressor therapy and low-dose hydrocortisone administration. In the absence of oliguria, continuous renal replacement therapy (CRRT) was started (continuous venovenous hemodiafiltration modality; effluent of 35–40 ml/kg.h) with a high cutoff (HCO) filter (Septex®) in combination with a cartridge column (CC; Cytosorb®). A significant reduction of vasopressor doses was observed 48 hours after the initiation of EBT (Fig. 1). A similar positive trend was observed for lactate (74 vs 32 mg/dl) and procalcitonin (65 vs 18 ng/ml) concentrations. This “hybrid” EBT was continued for 72 hours without adverse events. The patient was successfully discharged after 10 days. The blood cultures yielded Klebsiella pneumonia, related to a percutaneously inserted central line infection.
Fig. 1

Vasopressor and inotrope infusion rates during extracorporeal blood purification (EBT)

In this case, the benefits of CRRT in the management of fluid overload and metabolic abnormalities in children with septic shock were associated with the immune-modulatory effects of EBTs. HCO filters are characterized by large pore size (e.g., cutoff value of 70 kDa) with improved convective clearance of middle molecular weight molecules, such as cytokines [3]. CCs have a large surface area that could also directly adsorb and clear inflammatory mediators [4]. The combination of HCO-CRRT and CC might have a synergistic effect in this setting [5]; this association has not yet been explored in the treatment of pediatric septic shock. Further studies are needed to assess the feasibility as well as the optimal timing of initiation of such an approach in children suffering from septic shock.

Notes

Acknowledgements

Not applicable.

Funding

No funding to declare.

Availability of data and materials

The datasets during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Consent for publication of clinical data was given by the child’s parent.

Ethics approval and consent to participate

Not applicable.

References

  1. 1.
    Zhou F, Peng Z, Murugan R, Kellum JA. Blood purification and mortality in sepsis: a meta-analysis of randomized trials. Crit Care Med. 2013;41(9):2209–20.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kellum JA, Gómez H, Gómez A, Murray P, Ronco C, ADQI XIV WORKGROUP. Acute dialysis quality initiative (adqi) xiv sepsis phenotypes and targets for blood purification in sepsis: the bogotá consensus. Shock. 2016;45(3):242–8.CrossRefPubMedGoogle Scholar
  3. 3.
    Morgera S, Slowinski T, Melzer C, et al. Renal replacement therapy with high cutoff hemofilters: impact of convenction and diffusion on cytokine clearance and protein status. Am J Kidney Dis. 2004;43:444–53.CrossRefPubMedGoogle Scholar
  4. 4.
    Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004;32(3):801–5.CrossRefPubMedGoogle Scholar
  5. 5.
    Honore P, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS-a pragmatic approach for beduine intensivists summarizing the more recent advances: a systematic structured review. ASAJO J. 2013;59:99–106.CrossRefGoogle Scholar

Copyright information

© The Author(s). 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Istituto Giannina Gaslini, Neonatal and Paediatric Intensive Care UnitGenoaItaly
  2. 2.Department of Intensive CareHopital ErasmeBrusselsBelgium

Personalised recommendations